Breaking News Instant updates and real-time market news.

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

05:01
11/21/18
11/21
05:01
11/21/18
05:01

DexCom, Alphabet's Verily amend collaboration and license agreement

DexCom (DXCM) and Verily, an Alphabet (GOOG, GOOGL) company, announced last night an amendment to their collaboration and license agreement surrounding the ongoing development efforts between the companies. "The revised terms are intended to reinforce the companies' mutual product development goals, while expanding options for future collaborations," said the companies. "The agreement also accelerates Dexcom's efforts to advance into the Type 2 diabetes space and improves its future profitability," they added. In consideration of Verily's performance of its obligations under the joint development plan, the licenses granted to Dexcom and the amendment of the original agreement, Dexcom will make an upfront payment, as well as potential future milestone payments upon the achievement of certain goals, as follows: Dexcom will make an initial payment of $250M in shares of its common stock. The issuance of shares of common stock is subject to customary closing conditions, including expiration of any waiting period under the Hart-Scott-Rodino Act, and, if these conditions are not met, Dexcom would be obligated to make this payment in cash; Additional milestone payments of up to $280M may become due and payable by Dexcom upon the achievement of future product launch and revenue milestones. Dexcom may make up to $275M of these milestone payments in shares of its common stock, subject to customary closing conditions. They companies added: "Agreement strengthens product development timelines for the second generation CGM system. Dexcom will continue to evaluate near-term opportunities for the first generation product, and the company's focus shifts to commercializing the second generation offering; Agreement structure increases synergy with Verily's Onduo franchise, where Dexcom will be the preferred CGM device supplier into Onduo's Type 2 diabetes management program."

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

DXCM DexCom
$119.89

-1.34 (-1.11%)

11/07/18
OPCO
11/07/18
NO CHANGE
Target $150
OPCO
Outperform
DexCom price target raised to $150 form $125 at Oppenheimer
Oppenheimer analyst Steven Lichtman raised his price target for DexCom to $150 from $125 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/12/18
PIPR
11/12/18
NO CHANGE
PIPR
Piper continues to like pure play diabetes stocks after conference
Piper Jaffray analyst JP McKim left this weekend's Diabetes Technology Meeting feeling that DexCom (DXCM) "has a lot in its pipeline" and remains a few steps ahead of the competition, Insulet (PODD) is having "great success" in the pharmacy and is on the forefront of cybersecurity, and Tandem Diabetes (TNDM) remains in a "strong position to take market share." The analyst continues to like pure play diabetes names and keeps an Overweight rating on all three names.
11/07/18
JEFF
11/07/18
NO CHANGE
Target $148
JEFF
Buy
DexCom price target raised to $148 from $125 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for DexCom (DXCM) to $148 saying the company posted "strong" Q3 results. Improving market access from pharmacy benefit is driving patient adds and helping blunt any advantage for Abbott's (ABT) Libre, says the analyst. He keeps a Buy rating on DexCom citing strong G6 adoption, new patients accelerating and still underpenetrated markets.
11/07/18
SPHN
11/07/18
NO CHANGE
Target $170
SPHN
Overweight
DexCom price target raised to $170 from $160 at Stephens
Stephens analyst Chris Cooley raised his price target on DexCom shares to $170 from $160 following the company's Q3 report and revenue guidance increase. He sees DexCom being well positioned to continued posting organic growth "in the top echelon of med tech" while realizing operating leverage. Cooley maintains an Overweight rating on DexCom shares.
GOOG Alphabet
$1,026.00

7 (0.69%)

11/19/18
JMPS
11/19/18
NO CHANGE
Target $1375
JMPS
Outperform
JMP says former Oracle exec well positioned to keep scaling Google Cloud
Following Google's announcement last week that Google Cloud CEO Diane Greene is stepping down in January and being replaced in that role by Thomas Kurian, who most recently served as President of Product Development at Oracle (ORCL), JMP Securities analyst Ronald Josey said he was somewhat surprised but believes Kurian is well positioned to continue scaling Google Cloud and growing its sales force. Josey maintains an Outperform rating and $1,375 price target on shares of Google parent Alphabet (GOOGL).
11/15/18
MSCO
11/15/18
NO CHANGE
MSCO
Morgan Stanley highlights four tech stocks to buy following recent pullback
Morgan Stanley analysts Katy Huberty, Keith Weiss, Brian Nowak, Joe Moore, James Faucette and Brian Essex collaborated on a report addressing technology stocks following the recent market pullback, contending the fact that technology sector concentration remains near all-time highs suggests that its "probably too early" to buy the sector broadly. However, they highlight four stocks - Alphabet (GOOGL), Take-Two Interactive (TTWO), Microsoft (MSFT) and Xilinx (XLNX) - for which they believe the pullback is not fundamentally driven and the companies have strong secular tailwinds. The firm's analyst call these four stocks their "highest conviction" names and maintain Overweight ratings on all four.
11/14/18
LEHM
11/14/18
NO CHANGE
Target $1400
LEHM
Overweight
Barclays removes Alphabet as Top Pick, keeps Overweight rating
Barclays analyst Ross Sandler removed Alphabet (GOOGL) as his Top Pick and did not replace it with another stock. The analyst, however, keeps an Overweight rating on the shares with a $1,400 price target.
11/13/18
BARD
11/13/18
NO CHANGE
BARD
Amazon selection of East Coast corridor for HQs makes sense, says Baird
Baird analyst Colin Sebastian noted that he'd predicted last October that Washington DC was "a slight favorite in the HQ2 sweepstakes," and he believes Amazon's (AMZN) selection of a second headquarters divided between Long Island City, NY and Arlington, Virginia "makes logical sense." He sees the primary motivation for the HQ split was talent availability, Sebastian added. The analyst maintains an Outperform rating and $2,100 price target on Amazon shares. Adding that "it did not receive the headlines of the HQ2 bidding process," Google (GOOGL) is said by the Wall Street Journal to be acquiring space for an additional 12-14K employees in New York, Sebastian also noted.
GOOGL Alphabet Class A
$1,031.22

4.99 (0.49%)

TODAY'S FREE FLY STORIES

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:44
12/18/18
12/18
20:44
12/18/18
20:44
Hot Stocks
Benefitfocus sees FY19 revenue growth in 'mid-to-high teens' »

Sees FY19 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

AGCO

Agco

$56.59

2.7 (5.01%)

20:36
12/18/18
12/18
20:36
12/18/18
20:36
Earnings
Agco guides initial FY19 EPS ~$4.60, consensus $4.59 »

Sees FY19 revenue around…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NVS

Novartis

$85.40

-0.4 (-0.47%)

20:28
12/18/18
12/18
20:28
12/18/18
20:28
Hot Stocks
Novartis announces licensing of pradigastat to Anji Pharmaceuticals »

Anji Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

SQ

Square

$59.91

1.28 (2.18%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Recommendations
Square analyst commentary at Tigress Financial »

Square offers continued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PAYX

Paychex

$64.32

-0.63 (-0.97%)

, GIS

General Mills

$36.70

-0.03 (-0.08%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$64.32

-0.63 (-0.97%)

GIS

General Mills

$36.70

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

FSNUY

Fresenius SE

$0.00

(0.00%)

20:21
12/18/18
12/18
20:21
12/18/18
20:21
Upgrade
Fresenius SE rating change at Goldman Sachs »

Fresenius SE upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:19
12/18/18
12/18
20:19
12/18/18
20:19
Recommendations
Benefitfocus analyst commentary at Jefferies »

Benefitfocus analyst day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FN

Fabrinet

$51.13

2.17 (4.43%)

20:06
12/18/18
12/18
20:06
12/18/18
20:06
Recommendations
Fabrinet analyst commentary at Piper Jaffray »

Fabrinet among the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$33.96

0.17 (0.50%)

19:38
12/18/18
12/18
19:38
12/18/18
19:38
Upgrade
Sealed Air rating change at BMO Capital »

Sealed Air upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$124.29

-0.2 (-0.16%)

19:31
12/18/18
12/18
19:31
12/18/18
19:31
Hot Stocks
Vice President of Caterpillar Excavation unit to step down »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$71.99

-2.01 (-2.72%)

19:10
12/18/18
12/18
19:10
12/18/18
19:10
Periodicals
Exxon tells EPA it opposes weakening Obama-era emissions rules, Reuters says »

Exxon Mobil issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

CBS

CBS

$46.21

-0.6 (-1.28%)

, DIS

Disney

$109.43

-1.2 (-1.08%)

19:07
12/18/18
12/18
19:07
12/18/18
19:07
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's (CBS) board is…

CBS

CBS

$46.21

-0.6 (-1.28%)

DIS

Disney

$109.43

-1.2 (-1.08%)

FOX

21st Century Fox

$48.49

-0.29 (-0.59%)

FOXA

21st Century Fox

$48.78

-0.22 (-0.45%)

TRCO

Tribune Media

$45.25

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 05

    Feb

JBL

Jabil

$22.21

0.65 (3.01%)

, SCS

Steelcase

$14.19

0.02 (0.14%)

19:02
12/18/18
12/18
19:02
12/18/18
19:02
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil

$22.21

0.65 (3.01%)

SCS

Steelcase

$14.19

0.02 (0.14%)

ADMS

Adamas Pharmaceuticals

$8.11

-0.67 (-7.63%)

ANGI

Angi Homeservices

$15.64

-0.01 (-0.06%)

MU

Micron

$34.12

0.23 (0.68%)

LRCX

Lam Research

$138.01

2.39 (1.76%)

AMAT

Applied Materials

$33.27

0.62 (1.90%)

FDX

FedEx

$185.01

2.81 (1.54%)

UPS

UPS

$97.25

0.33 (0.34%)

SURF

Surface Oncology

$7.35

-0.44 (-5.65%)

GSAT

Globalstar

$0.36

0.0082 (2.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 08

    Jan

  • 19

    Dec

CBS

CBS

$46.21

-0.6 (-1.28%)

18:45
12/18/18
12/18
18:45
12/18/18
18:45
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's board is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

AMTB

Mercantil Bank

$12.00

-0.3 (-2.44%)

18:41
12/18/18
12/18
18:41
12/18/18
18:41
Syndicate
Mercantil Bank 6.3M share IPO priced at $13.00 per share »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

QDEL

Quidel

$50.00

0.9 (1.83%)

18:39
12/18/18
12/18
18:39
12/18/18
18:39
Hot Stocks
Quidel receives CE Mark for Sofia 2 Lyme+ FIA for use with Sofia 2 instrument »

Quidel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

, ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

18:34
12/18/18
12/18
18:34
12/18/18
18:34
Recommendations
Applied Optoelectronics, Acacia Communications, Cisco, Fabrinet, Finisar analyst commentary at Piper Jaffray »

Cisco's Luxtera deal…

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

CSCO

Cisco

$44.05

-0.16 (-0.36%)

FN

Fabrinet

$51.13

2.17 (4.43%)

FNSR

Finisar

$21.57

0.005 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

WGO

Winnebago

$19.96

-0.73 (-3.53%)

18:20
12/18/18
12/18
18:20
12/18/18
18:20
Hot Stocks
Winnebago to withdraw its Chicago Stock Exchange listing »

Winnebago Industrie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CVS

CVS Health

$69.55

-1.12 (-1.58%)

, AET

Aetna

$0.00

(0.00%)

18:07
12/18/18
12/18
18:07
12/18/18
18:07
Periodicals
Judge weighs naming monitor to oversee CVS during court process, Reuters says »

Judge Richard Leon of the…

CVS

CVS Health

$69.55

-1.12 (-1.58%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

FDX

FedEx

$185.01

2.81 (1.54%)

, AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

18:05
12/18/18
12/18
18:05
12/18/18
18:05
Hot Stocks
FedEx sees no impact from Amazon's air freight ops »

FedEx (FDX) says it is…

FDX

FedEx

$185.01

2.81 (1.54%)

AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 04

    Jan

  • 07

    Jan

VZ

Verizon

$55.67

-0.29 (-0.52%)

18:04
12/18/18
12/18
18:04
12/18/18
18:04
Hot Stocks
Verizon Media Group will replace the Oath brand »

Oath COO Guru Gowrappan …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CE

Celanese

$85.39

0.98 (1.16%)

18:02
12/18/18
12/18
18:02
12/18/18
18:02
Hot Stocks
Celanese raises GUR and GHR grades engineered materials prices by 10% »

Celanese announced price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$185.01

2.81 (1.54%)

17:55
12/18/18
12/18
17:55
12/18/18
17:55
Hot Stocks
Breaking Hot Stocks news story on FedEx »

FedEx says profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FDX

FedEx

$185.01

2.81 (1.54%)

17:52
12/18/18
12/18
17:52
12/18/18
17:52
Hot Stocks
FedEx sees voluntary buyout saving company $225M-$275M in FY20 »

Sees 18-24 month payback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VVV

Valvoline

$19.00

0.21 (1.12%)

17:51
12/18/18
12/18
17:51
12/18/18
17:51
Hot Stocks
Valvoline to open 17 acquired Quick-Lube centers in California »

Valvoline Inc. - a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.